Metabolic Brain Disease

SJR Rank #4,949H-index: 87SJR: 0.995Best quartile: Q2APC: US$4,590
Journal website: aims, scope and author guidelines
Publisher

Springer

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • BiochemistryQ2
  • Cellular and Molecular NeuroscienceQ2
  • Neurology (clinical)Q2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience

Most published research topics

Neuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration MechanismsLiver Disease and TransplantationMetabolism and Genetic DisordersTryptophan and brain disordersAlzheimer's disease research and treatmentsMitochondrial Function and PathologyLiver Disease Diagnosis and TreatmentDiet and metabolism studiesStress Responses and Cortisol

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025085170255340

Detailed Information

ISSN

1573-7365, 0885-7490

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

4.18

References per Document

70.66

Coverage

1986-2026

Scope

Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.

Metrics from SCImago Journal Rank 2025. View on SCImago